6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05446168 (ClinicalTrials.gov) | July 1, 2022 | 1/7/2022 | Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation | Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation | Parkinson Disease | Drug: tributyrin | Nicolaas Bohnen, MD, PhD | NULL | Recruiting | 45 Years | N/A | All | 20 | Phase 1 | United States |